Abeta25-35 enhanced NF-κB binding activity and protein production of NF-κB p-p65, p-p38, iNOS, and RAGE, which led to the massive generation of downstream oxidative and inflammatory factors, and consequently facilitated the progression of AD [29, 30]. This evidence concerns the gene MAPK14 and Alzheimer disease.